These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 16337798

  • 1. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, Dhenain M.
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [Abstract] [Full Text] [Related]

  • 2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 3. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [Abstract] [Full Text] [Related]

  • 5. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA, Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH, Howlett DR.
    Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121
    [Abstract] [Full Text] [Related]

  • 6. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS, Lamb BT.
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [Abstract] [Full Text] [Related]

  • 7. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.
    Dhenain M, El Tannir El Tayara N, Wu TD, Guégan M, Volk A, Quintana C, Delatour B.
    Neurobiol Aging; 2009 Jan; 30(1):41-53. PubMed ID: 17588710
    [Abstract] [Full Text] [Related]

  • 8. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 9. Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD.
    Lewis HD, Beher D, Smith D, Hewson L, Cookson N, Reynolds DS, Dawson GR, Jiang M, Van der Ploeg LH, Qian S, Rosahl TW, Kalaria RN, Shearman MS.
    Neurobiol Aging; 2004 Oct; 25(9):1175-85. PubMed ID: 15312963
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK, Curran GL, Holasek SS, Gilles EJ, Wengenack TM, Poduslo JF.
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.
    Puoliväli J, Wang J, Heikkinen T, Heikkilä M, Tapiola T, van Groen T, Tanila H.
    Neurobiol Dis; 2002 Apr; 9(3):339-47. PubMed ID: 11950278
    [Abstract] [Full Text] [Related]

  • 12. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
    Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR.
    Neurobiol Aging; 2004 Aug; 25(7):885-92. PubMed ID: 15212842
    [Abstract] [Full Text] [Related]

  • 13. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N, Glennon J, Koistinaho J, Banerjee P, Tanila H.
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [Abstract] [Full Text] [Related]

  • 14. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA.
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [Abstract] [Full Text] [Related]

  • 15. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
    Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett KW, Connor K, Melachrino J, O'Callaghan JP, Morgan D.
    Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
    [Abstract] [Full Text] [Related]

  • 16. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puoliväli J.
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [Abstract] [Full Text] [Related]

  • 17. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM, Koistinaho M, Pärepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J.
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [Abstract] [Full Text] [Related]

  • 18. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP.
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [Abstract] [Full Text] [Related]

  • 19. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 20. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lütjohann D, Hartmann T, Tanila H.
    Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.